Profound Medical Corp Stock Fundamentals
| PROF Stock | USD 8.15 0.31 3.95% |
Profound Medical Corp fundamentals help investors to digest information that contributes to Profound Medical's financial success or failures. It also enables traders to predict the movement of Profound Stock. The fundamental analysis module provides a way to measure Profound Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Profound Medical stock.
At this time, Profound Medical's Reconciled Depreciation is most likely to increase significantly in the upcoming years. Profound | Select Account or Indicator |
Profound Medical Corp Company Return On Equity Analysis
Profound Medical's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Profound Medical Return On Equity | -0.9 |
Most of Profound Medical's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Profound Medical Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Profound Total Stockholder Equity
Total Stockholder Equity |
|
Based on the latest financial disclosure, Profound Medical Corp has a Return On Equity of -0.9017. This is 96.24% lower than that of the Health Care Equipment & Supplies sector and 89.67% lower than that of the Health Care industry. The return on equity for all United States stocks is 190.87% higher than that of the company.
Profound Medical Corp Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Profound Medical's current stock value. Our valuation model uses many indicators to compare Profound Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Profound Medical competition to find correlations between indicators driving Profound Medical's intrinsic value. More Info.Profound Medical Corp is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Profound Medical's Return On Equity is most likely to slightly grow in the upcoming years. Comparative valuation analysis is a catch-all technique that is used if you cannot value Profound Medical by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Profound Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Profound Medical's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Profound Medical could also be used in its relative valuation, which is a method of valuing Profound Medical by comparing valuation metrics of similar companies.Profound Medical is currently under evaluation in return on equity category among its peers.
Profound Medical ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Profound Medical's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Profound Medical's managers, analysts, and investors.Environmental | Governance | Social |
Profound Fundamentals
| Return On Equity | -0.9 | ||||
| Return On Asset | -0.45 | ||||
| Operating Margin | (3.17) % | ||||
| Current Valuation | 176.33 M | ||||
| Shares Outstanding | 24.66 M | ||||
| Shares Owned By Insiders | 8.39 % | ||||
| Shares Owned By Institutions | 43.81 % | ||||
| Number Of Shares Shorted | 348.04 K | ||||
| Price To Book | 6.47 X | ||||
| Price To Sales | 22.37 X | ||||
| Revenue | 7.2 M | ||||
| Gross Profit | 3.02 M | ||||
| EBITDA | (26.78 M) | ||||
| Net Income | (29.09 M) | ||||
| Cash And Equivalents | 46.21 M | ||||
| Cash Per Share | 2.21 X | ||||
| Total Debt | 7.94 M | ||||
| Debt To Equity | 0.02 % | ||||
| Current Ratio | 17.36 X | ||||
| Book Value Per Share | 1.26 X | ||||
| Cash Flow From Operations | (22.3 M) | ||||
| Short Ratio | 8.05 X | ||||
| Earnings Per Share | (1.34) X | ||||
| Target Price | 15.17 | ||||
| Number Of Employees | 131 | ||||
| Beta | 0.83 | ||||
| Market Capitalization | 200.99 M | ||||
| Total Asset | 43.91 M | ||||
| Retained Earnings | (217.93 M) | ||||
| Working Capital | 35.53 M | ||||
| Current Asset | 9 K | ||||
| Current Liabilities | 761 K | ||||
| Net Asset | 43.91 M |
About Profound Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Profound Medical Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Profound Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Profound Medical Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 717.3 K | 383.6 K | |
| Total Revenue | 7.2 M | 4.7 M | |
| Cost Of Revenue | 2.8 M | 2.7 M | |
| Stock Based Compensation To Revenue | 0.47 | 0.41 | |
| Sales General And Administrative To Revenue | 1.27 | 1.63 | |
| Research And Ddevelopement To Revenue | 2.00 | 2.51 | |
| Capex To Revenue | 0.10 | 0.08 | |
| Revenue Per Share | 0.34 | 0.42 | |
| Ebit Per Revenue | (3.97) | (4.17) |
Currently Active Assets on Macroaxis
When determining whether Profound Medical Corp is a strong investment it is important to analyze Profound Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Profound Medical's future performance. For an informed investment choice regarding Profound Stock, refer to the following important reports:Check out Profound Medical Piotroski F Score and Profound Medical Altman Z Score analysis. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Profound Medical. If investors know Profound will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Profound Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.34) | Revenue Per Share 0.38 | Quarterly Revenue Growth 0.639 | Return On Assets (0.45) | Return On Equity (0.90) |
The market value of Profound Medical Corp is measured differently than its book value, which is the value of Profound that is recorded on the company's balance sheet. Investors also form their own opinion of Profound Medical's value that differs from its market value or its book value, called intrinsic value, which is Profound Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Profound Medical's market value can be influenced by many factors that don't directly affect Profound Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Profound Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Profound Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Profound Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.